32
Participants
Start Date
January 16, 2018
Primary Completion Date
February 11, 2019
Study Completion Date
February 11, 2019
PM060184
"PM060184: 9.3 mg/m2 PM060184 i.v. as a 30-minute infusion via a central or peripheral venous catheter.Dose can be rounded to the first decimal point.~PM060184 will be administered on Day 1 and Day 8 q3wk. (Three weeks=one treatment cycle)."
ES009, Madrid
ES002, Valencia
US017, Los Angeles
CA001, Toronto
ES001, Barcelona
Lead Sponsor
PharmaMar
INDUSTRY